ScienceDaily: Top Health News |
A new brain-computer interface with a flexible backing Posted: 15 Mar 2022 01:50 PM PDT Engineering researchers have invented an advanced brain-computer interface with a flexible and moldable backing and penetrating microneedles. Adding a flexible backing to this kind of brain-computer interface allows the device to more evenly conform to the brain's complex curved surface and to more uniformly distribute the microneedles that pierce the cortex. The microneedles, which are 10 times thinner than the human hair, protrude from the flexible backing, penetrate the surface of the brain tissue without piercing surface venules, and record signals from nearby nerve cells evenly across a wide area of the cortex. This novel brain-computer interface has thus far been tested in rodents. |
Brain differences in children with binge eating disorder Posted: 15 Mar 2022 01:28 PM PDT Brain scans of children ages 9-10 with a type of eating disorder that causes uncontrollable overeating showed differences in gray matter density compared to their unaffected peers, according to a new study. The study's findings suggest that abnormal development in the brain's centers for reward and inhibition may play a role. In the children with binge eating disorder, researchers saw elevations in gray matter density in areas that are typically 'pruned' during healthy brain development. Disturbed synaptic pruning is linked to a number of psychiatric disorders. |
Pathogen and drug work together to fight fungal lung infection Posted: 15 Mar 2022 01:28 PM PDT Pathogens don't always work against drug treatments. Sometimes, they can strengthen them, according to new research. Researchers have now looked at two pathogens that often occur at similar sites, particularly in cystic fibrosis and mechanically ventilated patients: Candida albicans and Pseudomonas aeruginosa. The researchers investigated the effectiveness of an antifungal drug, fluconazole, with both pathogens. The results showed that P. aeruginosa works with fluconazole to eliminate drug tolerance and clear the C. albicans infection. The bacteria also enhance the drug's ability against a second pathogenic Candida species that tends to be more resistant to the drug. |
The immune system is very complicated, but now, it's on a chip Posted: 15 Mar 2022 12:01 PM PDT Scientists have a new tool to help them tease out the immune system's mysteries. Researchers cultured human B and T cells inside a microfluidic Organ Chip and coaxed them to form functional lymphoid follicles (LFs) -- structures that reside in lymph nodes and other parts of the human body and mediate immune responses. The LF Chip replicated human immune responses to both pathogens and a commercial influenza vaccine in vitro, offering significant improvement over existing preclinical models like cells in a dish and non-human primates. |
'Healthspan' increasing even for people with common chronic conditions Posted: 15 Mar 2022 11:20 AM PDT |
Molecular networks could explain racial disparity in triple negative breast cancer deaths Posted: 15 Mar 2022 11:18 AM PDT |
Fruit fly study uncovers functional significance of gene mutations associated with autism Posted: 15 Mar 2022 11:18 AM PDT Researchers applied sophisticated genetic strategies in laboratory fruit flies to determine the functional consequences of de novo variants identified in the Simons Simplex Collection (SSC), which includes approximately 2,600 families affected by autism spectrum disorder. Surprisingly, their work also allowed them to uncover a new form of rare disease due to a gene called GLRA2. |
Senolytic drugs boost key protective protein Posted: 15 Mar 2022 11:17 AM PDT |
Study shows link between socioeconomic deprivation and premature cardiovascular mortality Posted: 15 Mar 2022 11:17 AM PDT |
Immune cells linked to neurological disease prognosis and survival Posted: 15 Mar 2022 09:14 AM PDT |
Cell fusion ‘awakens’ regenerative potential of human retina Posted: 15 Mar 2022 09:14 AM PDT Fusing human retinal cells with adult stem cells could be a potential therapeutic strategy to treat retinal damage and visual impairment, according to the findings of a new study. The hybrid cells were injected into a growing retinal organoid, a model that closely resembles the function of the human retina. The researchers found that the hybrid cells successfully engrafted into the tissue and differentiated into cells that closely resemble ganglion cells, a type of neuron essential for vision. The hybrid cells act by awakening the regenerative potential of human retinal tissue, previously only thought to be the preserve of cold-blood vertebrates. |
Living near green areas reduces the risk of suffering a stroke by 16 percent, study finds Posted: 15 Mar 2022 08:30 AM PDT The risk of suffering an ischaemic stroke, the most common type of cerebrovascular event, is 16 percent less in people who have green spaces less than 300 meters from their homes. The study took into account information on exposure to three atmospheric pollutants linked to vehicle traffic in more than three and a half million people selected from among the 7.5 million residents of Catalonia, over the age of eighteen who had not suffered a stroke prior to the start of the study. |
Permeability of the blood-brain barrier in mice Posted: 15 Mar 2022 08:30 AM PDT |
Vaccine protects against 'tough cookie' parasite found in the Americas Posted: 15 Mar 2022 08:30 AM PDT |
Reduced inhibition of hippocampal neurons impairs long-term memory recall in Rett syndrome Posted: 15 Mar 2022 08:30 AM PDT |
When it comes to sleep, it’s quality over quantity Posted: 15 Mar 2022 08:29 AM PDT Some people are gifted with genes that pack the benefits of slumber into an efficient time window, keeping them peppy on only four or six hours of sleep a night. In addition, the scientists said, these 'elite sleepers' show psychological resilience and resistance to neurodegenerative conditions that may point the way to fending off neurological disease. |
Treating cancer with light-sensitive nanoscale biomaterials Posted: 15 Mar 2022 08:29 AM PDT Treating cancer and other diseases with laser light is not currently considered routine, but new approaches using nanoparticles show some promise in improving existing techniques. Researchers review the status of the field and by combining photothermal therapy or photodynamic therapy with nanomaterials, they have been able to apply these types of phototherapies while also delivering drugs to sites in the body that are otherwise inaccessible. It is also possible to combine PTT and PDT into a single treatment, creating an even more powerful treatment method. |
Scientists find brain network that makes mice mingle Posted: 15 Mar 2022 08:29 AM PDT The difference between a social butterfly and a lone wolf is actually at least eight differences, according to new findings by a team of brain researchers. By simultaneously spying on the electrical activity of several brain regions, researchers can both identify how social or solitary an individual mouse is, and, by zapping nodes within this social brain network, can prompt mice to be even more gregarious. |
'Long COVID' linked to lasting airways disease Posted: 15 Mar 2022 07:56 AM PDT |
Posted: 15 Mar 2022 07:56 AM PDT A new study in animals suggests that high doses of a widely used antibiotic called rifampin may safely treat and reduce the duration of treatment for the deadliest form of tuberculosis that affects the brain, potentially improving survival rates for patients and decreasing the likelihood of lasting adverse effects of the disease. |
People with diabetes who eat less processed food at night may live longer Posted: 15 Mar 2022 06:50 AM PDT |
Elevated inflammation persists in immune cells months after mild COVID-19 Posted: 15 Mar 2022 06:50 AM PDT |
Mechanism linking type 2 diabetes to Alzheimer’s disease Posted: 15 Mar 2022 06:50 AM PDT |
Discovery of novel brain fear mechanisms offers target for anxiety-reducing drugs Posted: 15 Mar 2022 06:50 AM PDT A new target in the brain which underpins the eliciting of anxiety and fear behaviors such as 'freezing' has been identified by neuroscientists. Researchers say the discovery of a key pathway in the brain offers a potential new drug target for treating anxiety and psychological disorders, which affect an estimated 264-million people worldwide. |
Malaria drug could combat chemotherapy-resistant head and neck cancers, research suggests Posted: 14 Mar 2022 12:44 PM PDT |
A third of new moms during early COVID had postpartum depression Posted: 14 Mar 2022 11:20 AM PDT |
Link between high cholesterol and heart disease 'inconsistent', new study finds Posted: 14 Mar 2022 09:07 AM PDT |
Metastatic prostate cancer on the rise since decrease in cancer screenings Posted: 14 Mar 2022 09:07 AM PDT |
Photo or the real thing? Mice can inherently recall and tell them apart, experiments show Posted: 14 Mar 2022 06:57 AM PDT The ability to make perceptual and conceptual judgements such as knowing the difference between a picture of an object and the actual 3D object itself has been considered a defining capacity of primates, until now. A study provides the very first behavioral evidence that laboratory mice are capable of higher-order cognitive processes. Findings also provide strong support that the mouse's hippocampus, like that of humans, is required for this form of nonspatial visual recognition memory and picture-object equivalence. |
Fight friendly fire with fire: An antibody for treating autoimmune disease Posted: 11 Mar 2022 10:27 AM PST Researchers have found that repulsive guidance molecule-a (RGMa) induces macrophages to recruit neutrophils to nerve lesions in neuromyelitis optica, where they kill off astrocytes, causing pain and paralysis. Treating rats with an anti-RGMa antibody interrupted this signaling process, resulting in decreased neutrophil recruitment, increased astrocyte survival, and improvement in disease-associated symptoms. |
You are subscribed to email updates from Top Health News -- ScienceDaily. To stop receiving these emails, you may unsubscribe now. | Email delivery powered by Google |
Google, 1600 Amphitheatre Parkway, Mountain View, CA 94043, United States |